Past Issue

Volume 10, Number 2, Jul-Sep 2016, Pages: 232-238

Original Article(s)

Attenuation of Methotrexate-Induced Embryotoxicity and Oxidative Stress by Ethyl Pyruvate

Gholamreza Najafi, D.V.Sc, 1Elham Atashfaraz, M.Sc, 2,*Farah Farokhi, Ph.D, 2
Department of Basic Sciences (Anatomy and Embryology), Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
Department of Biology, Faculty of Science, Urmia University, Urmia, Iran
*Corresponding Address: Department of Biology Faculty of Sci- ence Urmia University Urmia Iran



Methotrexate (MTX), as an anti-folate agent, is widely used in the treatment of rheumatic disorders and malignant tumors, however it damages reproductive sys- tem in mice. The aim of this research was to study the effects of ethyl pyruvate (EP) on embryo development and oxidative stress changes in the testis of mice treated with MTX.

Materials and Methods

In this experimental study, thirty-two adult male Naval Medical Research Institute mice, with average weight of 26 ± 2 g, were divided into four groups. The first group (control) received distilled water (0.1 ml/mice/day), while the second group was intraperitoneally (IP) treated with 20 mg/kg MTX once per week. The third group was IP treated with 40 mg/kg/day EP, and the fourth group was IP treated with both 20 mg/kg MTX and 40 mg/kg/day EP for 30 days. At the end of treatment fertilization rate and embryonic development were evaluated. Differences between these groups were assessed by ANOVA using the SPSS software package for Windows with a Tukey-Kramer multiple post-hoc comparison test.


MTX treatment caused significant (P<0.05) increase in malondialdehyde (MDA) and reduced catalase (CAT), as well as leading to in vitro fertilization (IVF) and embryonic development. The improved effects of EP on the IVF were determined by the reduced level of MDA (index of oxidative stress) and significant increased level of CAT (a key antioxidant). We observed significant increase in fertilization rate and embryonic development in the treated group with both MTX and EP.


It is suggested that EP can be useful in ameliorating testicular damages and embryotoxicity induced by MTX. These effects could be attributed to its antioxidant properties.


Infertility has been one of the most controversial medical and social issues. It was previously proposed as a punishment in some civilizations, while it is an illness (1). In addition, lack of the knowledge on medicine is generally the main factor to always consider female as responsible for reproductive system failure. Several investigations within the last decade help scientists and clinicians distinguish crucial parameters involved in couple’s infertility, one of which is sperm malfunction in male (2). About 5-15% of couples are infertile, out of whom about 50% of infertility is caused by male disorders (3). Methotrexate (MTX) is an anti-neoplastic agent which is used alone or in combination with other agents to treat severe psoriasis and rheumatoid arthritis (4). It is also used against a broad range of neoplastic disorders including acute lymphoblastic leukemia, non-Hodgkin’s lymphoma, breast cancer and testicular tumors (5,6).

It is well demonstrated that cancer chemotherapeutic drugs could cause acute toxic side-effects in multiple organs such as gastrointestinal tract, lung, kidney, liver, testes and skin. Several currently available anti-cancer drugs, specifically MTX, generally function by destruction of particular proliferating cells with both normal and malignant origins (7,8). MTX might also cause primary infertility by affecting hypothalamic-pituitary-gonadal axis or gonads, directly (9). This drug is bound to dihydrofolate-reductase enzyme, which inhibits DNA replication and prevents the synthesis of purines, thymidilate as well as glycine, eventually leading to cell death (10). It has been manifested that MTX, as a cytotoxic agent, should be considered a potential occupational reproductive hazard which is harmful for the fetus, and could potentially cause human carcinogenesis (11). Study of this drug in animal models showed cytotoxicity, altered spermatogenesis, degeneration of spermatocytes in sertoli and leydig cells (12,13).

On the other hand, pyruvate is a key intermediate metabolite of glucose, playing role as a potent anti-oxidant and free scavenger. It has been demonstrated that pyruvate has also an anti-inflammatory effect, both in vitro and in vivo (14). While being a good scavenger for hydrogen peroxide and superoxide radicals (15), the efficiency of pyruvate as a therapeutic agent is limited by its instability (16). In comparison, ethyl pyruvate (EP), a simple aliphatic ester derived from pyruvic acid, is safer and more stable than pyruvate (17). Similar to pyruvate, EP can rapidly and stoichiometrically scavenge hydrogen peroxide. Investigations showed that treatment with EP reduces oxidative stress both in vitro and in vivo models of ischemia/reperfusion injury (15).

In vitrofertilization (IVF), is a safe and effective way and the last option for the infertile couples who have tried and failed to conceive using standard treatments such as surgery, fertility drugs and artificial insemination (18). The aim of this research was to study the effect of EP on embryo development and oxidative stress changes in mice testis treated with MTX.

Materials and Methods


This was an experimental study on thirty two adult male Naval Medical Research Institute mice with 8-10 weeks of age and 26 ± 2 g average weight. The mice were purchased from animal house of Science Faculty of Urmia University (Urmia, Iran). All animals were kept under standard environmental conditions, including 22 ± 2°C room temperature, relative humidity of 50 ± 10% and a dark/light photoperiod of 12/12 hours, respectively. The animals had open access to standard diet pellets, water and libitum. This study was performed according to Ethical Committee Guidance for Research at Laboratory Animals of Urmia University.

Experimental design

Animals were randomly divided into four equal number groups and treated for 30 days. Group 1 (control) received 0.1 ml/mice/day distilled water intraperitoneally (IP). Group 2 mice were IP administered once per week with 20 mg/kg MTX. Group 3 was IP treated with 40 mg/kg/day EP. Group 4 received both MTX and EP treatment, with similar dosages to the individual treatments.

Oocyte collection

To perform assisted reproductive technique (ART) procedure, the oviduct ampullas was initially collected. Briefly, each male mouse (total number: 32) was mated with three female mice (total number: 96). Superovulation was induced in 6-7 weeks old female mice by IP injection of 10 IU pregnant mare serum gonadotropin (PMSG, Boxmeer, Netherlands), in addition to IP injection of 10 IU human chorionic gonadotropin (hCG, Folligon, Netherlands) after 48 hours. 12-14 hours after hCG injection, female mice were sacrificed by cervical vertebrae dislocation. The oviduct ampullas were removed and transferred to a petridish containing human tubular fluid (HTF, Sigma, St. Louis, USA) medium+4 mg/ml bovine serum albumin (BSA, Sigma, St. Louis, USA). The ampulla portions were distinguished by stereo microscope (Model TL2, Olympus Co., Japan), and oocytes were dissected out.

Preparation of culture media for in vitro fertilization

Required fertilization media was prepared and incubated for 12 hours in a gas mixture of 5% CO2 at 37°C, one day before conception. For each group, separate dishes were considered. Conception dishes with HTF medium were combined with 4 mg/ml BSA. Droplets of fertilization medium and washing HTF medium was prepared for the IVF dishes, followed by covering them with mineral oil (Sigma) and incubation at 37°C) for overnight.

Sperm preparation and insemination

24 hours after the last treatment, male mice were sacrificed by cervical dislocation. Using a ventral midline skin incision the epididymides were separated from the testicles. Afterward, caudal epididymis (cut into 2-3 pieces) was placed in 1 ml HTF medium with a combination of 4 mg/ml BSA and incubated at 37˚C for 60 minutes in a 5% CO2 incubator. Obtained sper-matozoa were capacitated by incubation at 37˚C and 5% CO2 for 1 hour.

In addition, 12-14 hours after injection of HCG, female mice were sacrificed by cervical dislocation. The ampules of fallopian tubes were removed, put in the HTF medium with 37°C temperature. The oocytes were subsequently removed with dissecting techniques, followed by washing with the HTF and transferring to the fertilization droplets under mineral oil containing HTF and 4 mg/ml BSA. As soon as overtaking capacitation step of the sperms, they were added to the medium, in a concentration of 1×106sperms/ml culture medium.

Assessment of fertilization and embryonic development

Using an inverted microscope (Model TL2, Olympus Co., Japan), fertilized oocytes were evaluated by appearance of the pronuclei (female and male) under magnitude of ×200. After denuding of granulosa cells and washing with HTF medium (100 µl), zygotes were transferred into pre-equilibrated fresh medium and cultured for five days. After 24 hours of zygote culture, the rate of two-cell embryos was assessed. Embryonic development was evaluated by inverted microscope after 120 hours culture in vitro. Intact, fragmented and/or lysed embryos, which have not been developed, were considered as "arrested embryos".

Catalase assay

Catalase (CAT) activity, based on the ability to decompose H2O2 in homogenized testicular tissue, was determined by Aebi method (19). By reducing the wavelength absorption at 240 nm in the absorption spectrum, decomposition of H2O2 was detectable. For this purpose, 30 mM hydrogen peroxide was used as substrate, followed by 50 mM phosphate buffer (pH=7) as an alternative substrate in the blank solution. The assay solution contained 2 ml tissue homogenate and 1 ml hydrogen peroxide. The reaction was started by adding H2O2 and using a spectrophotometer (pharmaciaп novaspec, and biochrom, England) at a wavelength of 240 nm. Decrease in absorbance was evaluated for 30 seconds and the values were expressed in terms of (µg)/g testis tissue.

Lipid peroxidation assay (Malondialdehyde)

Malondialdehyde (MDA) is a product of lipid peroxidation. This experiment is widely used as an oxidative stress index. 300 µl of 10% trichloroacetic acid was added to 150 µl of the sample and centrifuged at 1000 rpm for 10 minutes at 4°C. 300 µl of the supernatant was subsequently transferred to a test tube containing 300 µl of 67% thiobarbituric acid. The mixture was incubated for 25 minutes at 100°C. After cooling the solution for 5 minutes, a pink color was appeared due to the reaction between MDA and TBA and absorbance was measured using a spectrophotometer at 535 nm wavelength (20).

Statistical analysis

SPSS-21 software was used for statistical analysis. The results were compared by one-way ANOVA, supplemented with a Tukey-Kramer multiple comparison test. Values of less than 0.05 were considered statistically significant. All results were expressed as means ± SEM.


Fertilization and embryonic development

In this study, after 30 days, treated mice group with 20 mg/kg of MTX showed significantly reduced rate of fertilization as well as percentage of blastocysts (Table 1,,Fig.1,). Compared to this group, there was a significant increase in fertilization rate and blastocysts percentage of mice treated with both MTX and EP (Table 1,,Fig.2,). Findings also demonstrated that the range of two-cell embryos was reduced in zygotes obtained from the MTX treated mice, although this change was not significant (Table 1,,Fig.1,). In addition, no significant difference was observed in two-cell embryos among the all groups. Furthermore, percentage of the arrested embryos was enhanced after MTX treatment compared to the control group, after 30 days treatment (P<0.05). Analysis of the mice treated with EP showed a significant decrease in the percentage of arrested embryos in comparison with MTX group (Table 1,,Fig.3,).

Table 1- Effect of MTX and EP on fertilization and embryonic development of the mice
- Representative image of blastocysts embryo (arrow number 1) and hatching embryo (arrow number 2) in the control group. The image was captured with ×200 microscope magnitude.
- Representative image of blastocysts embryo (arrow number 1) and unfertilized oocytes (arrow number 2) in the Methotrexate (MTX) treated group. The image was captured with ×200 microscope magnitude.
Table 2- Effect of MTX and EP on CAT and MDA levels in the adult male mice.
- Representative image of blastocysts embryo (arrow number 1) and two-cell arrested embryo (arrow number 2) and unfertilized oocyte (arrow number 3) in the Methotrexate+ethyl pyruvate (MTX+EP) treated group. The image was captured with ×200 microscope magnitude.

Biochemical analysis

MTX administration for 30 days led to significant decrease in CAT level and increase in the level of MDA compared to the control. By the end of treatment period, EP administered groups showed significant increase in CAT and decrease in the MDA level compared to the MTX (Table 2,).


MTX, as a well-known anti-cancer agent with a narrow therapeutic window, is used for the treatment of malignant and non-malignant conditions (21). Although the cytotoxic effects of this agent has been determined in various organs (22). Several investigations implicated the potential negative effects of MTX on gonads. Thus, it is currently well known that administration of MTX can lead to reproductive system damages, including decreased epididymal and testicular weights, and reduced epididymal sperm counts and fertility rate (21). Sperm counts are a crude measure of fertility (23,24) and decrease in the count of sperm could often result from drug interference in the process of spermatogenesis and omission of sperm cells during different developmental stages (25). This agent also inhibits the synthesis of thymidylate, serine, and methionine, leading to disruption of DNA, RNA as well as protein function and consequently cell death (26). The sperm chromatin structure assay (SCSA) is an independent predictor of successful pregnancy (27). According to the results obtained from SCSA, Atashfaraz et al. (28) recently showed that MTX caused an increase in DNA fragmentation.

A single exposure study, using IP route, indicated the transmissibility potential of MTX, substantiating its teratogenicity and embryo-lethality effects (29,30). The toxic effect of MTX on gonads was clearly determined by study on the histological evaluation of testes. Several symptoms, including increased disorganization, vacuolization, decreased spermatogonial and spermatid counts in the seminiferous tubules, indicate that MTX interferes in the process of spermatogenesis (21). In addition, similar studies have been conducted, reporting damages in spermatogonia as well as spermatocytes after repeated treatments with MTX in rats (8,31). In terms of male fertility, further to the counts, motility of sperms is also an important factor. Significant increase in lipid peroxidation along with sperm motility reduction might be a consequence of oxidative stress status observed by MTX administration (32,33). It has also been demonstrated that MTX can reduce the fertilization rate, percentage of blastocysts while increasing percentage of arrested embryos, probably due to the effect of this agent on oxidative stress induction. Recent medical advances have indicated that oxygen radicals and hydrogen peroxides are in association with the undesired adverse effects of several anti-tumor drugs (34).

Free radicals are proposed to play a crucial role in MTX induced toxicity. In present study, we determined that level of MDA in the MTX-treated mice was significantly higher than the control group. This finding was consistent with several reports implicating that MTX induces oxidative stress in tissues by increasing MDA levels (35,34). The product of lipid peroxidation, MDA, and its level is widely used as an index of oxidative stress (36). Recent evidence has implicated oxidative stress as an etiological factor in the development of male infertility (37,38). Generally, men with significantly higher seminal reactive oxygen species (ROS) levels and lower antioxidant potential are diagnosed with idiopathic infertility (39). Zorn et al. (40) found that high seminal plasma ROS levels contribute to impaired sperm fertilization ability and lower pregnancy rates after IVF.

CAT is an hemoprotein, catalyzing H2O2 reduction and protects tissues from ROS and hydroxyl radical levels growth (41). CAT, acting as a preventative antioxidant, plays an important role in protection against the deleterious effects of lipid peroxidation (42). In this study, we showed that MTX-treatment significantly reduced CAT level in testicular tissue. On the other hand, EP induced a reduction in MDA value and significantly increased CAT level in the mice treated with both MTX and EP. Given the close similarity of EP to an endogenous metabolite, the safety profile in animals and common application of this agent as a food supplement (43), it is unlikely to be harmful to humans. EP, a marker for oxidative stress both in vitro (44) and in vivo (45), inhibits lipid peroxidation. Tsung et al. (46) has recently indicated that it also decreases lipid peroxidation in liver tissue. Moreover, EP can react with ROS via both oxidative carboxylation and formation of hydroxylated adducts at the 3-carbon (47).

Ultimately, we found that EP increased several fertility-related parameters, including fertilization rate and blastocysts percentage, and also reduced percentage of the arrested embryos probably due to its effect on the total antioxidant capacity and H2O2 scavengers.


The present study gives evidences of MTX-induced fertility damage and shows the capability of EP in preventing this damage by inhibiting the lipid peroxidation and improving the activity of antioxidant enzymes. The results of this study evaluated the efficacy of EP as a protective agent against the side-effects of chemotherapeutic agents.


We are grateful for the help and financial support of Urmia University in this study. There is no conflict of interest to declare.


Morice P, Josset P, Chapron C, Dubuisson JB. History of infertility. Hum Reprod Update. 1995; 1(5): 497-504.
Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed). 1985; 291(6510): 1693-1697.
Gaur DS, Talekar M, Pathak VP. Effect of cigarette smoking on semen quality of infertile men. Singapore Med J. 2007; 48(2): 119-123.
Chabner BA, Ryan DP, Ares LP, Carbonero RG, Calabresi PHardman JG, Limberd LE, edi- tors. The pharmacological basis of therapeutics. 10th ed.: New York: Mc Graw Hill and Co; 2002; 1399-1404.
Choudhury RC, Ghosh SK, Palo AK. Cytogenetic toxicity of methotrexate in mouse bone marrow. Environ Toxicol Pharmacol. 2000; 8(3): 191-196.
Jensen SB, Mouridsen HT, Reibel J, Brunner N, Nauntofte B. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncol. 2008; 44(2): 162-173.
EI-Beheiry A, EI-Mansy E, Kamel N, Salman N. Methotrexate and fertility in men. Arch Androl. 1979; 3(2): 177-179.
Russell LD, Russell JA. Short-term morphological response of the rat testis to administration of five chemotherapeutic agents. Amer J Anat. 1991; 192(2): 142-168.
Lewis SE, Sterling ES, Young IS, Thompson W. Comparison of individual antioxidants of sperm and seminal plasma in fertile and infertile men. Fertil Steril. 1997; 67(1): 142-147.
Donehower RC, Meyers CE, Chabner BA. New developments on the mechanism of action of antineoplastic drugs. Life Sci. 1979; 25(1): 1-14.
Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA. The effect of methotrexate on pregnancy, fertility and lactation. QJM. 1999; 92(10): 551-563.
Chow M, Koo J, Ng P, Rubin H. Random population-wide genetic damage induced in replicating cells treated with methotrexate. Mutat Res. 1998; 413(3): 251-264.
Gisondi P, Girolomoni G. Biologic therapies in psoriasis: a new therapeutic approach. Autoimmun Rev. 2007; 6(8): 515-519.
Varma SD, Hegde KR, Kovtun S. Oxidative damage to lens in culture: reversibility by pyruvate and ethyl pyruvate. Ophthalmologica. 2006; 220(1): 52-57.
Varma SD, Devamanoharan PS, Ali AH. Prevention of intracellular oxidative stress to lens by pyruvate and its ester. Free Radic Res. 1998; 28(2): 131-135.
Vonkorff RW. Pyruvate-C14, purity and stability. Anal Biochem. 1964; 8: 171-178.
Sims CA, Wattanasirichaigoon S, Menconi MJ, Ajami AM, Fink MP. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med. 2001; 29(8): 1513-1518.
Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978; 2(8085): 366-366.
Aebi H. Catalse in vitro. Methods Enzymol. 1984; 105: 121-126.
Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci. 2005; 8(3): 394-399.
Saxena AK, Dhungel S, Bhattacharya S, Jha CB, Srivastava AK. Effect of chronic low dose of methotrexate on cellular prolifreation during spermatogenesis in rat. Arch Androl. 2004; 50(1): 33-35.
Chiang HM, Fang SH, Wen KC, Hsiu SL, Tsai SY, Hou YC. Life threatening interaction between the root extract of Puerarialobata and methotrexate in rats. Toxicol Appl Pharmacol. 2005; 209(3): 263-268.
Padmanabhan S, Tripathi DN, Vikram A, Ramarao P, Jena GB. Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice. Mutat Res. 2008; 655(12): 59-67.
Abdel Aziz AH, Shouman SA, Attia AS, Saad SF. A study on the reproductive toxicity of erythrosine in male mice. Pharmacol Res. 1997; 35(5): 457-462.
Schimenti KJ, Hanneman WH, Schimenti JC. Evidence for cyclophosphamide-induced gene conversion and mutation in mouse germ cells. Toxicol Appl Pharmacol. 1997; 147(2): 343-350.
Grunnet E, Nyfors A, Hansen KB. Studies of human semen in topical corticosteroid-treated and in methotrexatetreated psoriatics. Dermatologica. 1977; 154(2): 78-84.
Bungum M, Bungum L, Giwercman A. Sperm chromatin structure assay (SCSA): a tool in diagnosis and treatment of infertility. Asian J Androl. 2011; 13(1): 69-75.
Atashfaraz E, Farokhi F, Najafi G. Protective effect of ethyl pyruvate on epididymal sperm characteristics, oxidative stress and testosterone level in methotrexate treated mice. J Reprod Infertil. 2013; 14(4): 190-196.
Khera KS. Teratogenicity studies with methotrexate, aminopterin, and acetylsalicylic acid in domestic cats. Teratology. 1976; 14(1): 21-27.
Skalko RG, Gold MP. Teratogenicity of methotrexate in mice. Teratology. 1974; 9(2): 159-163.
Shrestha S, Dhungel S, Saxena AK, Bhattacharya S, Maskey D. Effect of methotrexate (MTX) administration on spermatogenesis: an experiment on animal model. Nepal Med Coll J. 2007; 9(4): 230-233.
Jahovic N, Cevik H, Sehirli AO, Yeğen BC, Sener G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res. 2003; 34(4): 282-287.
Tabassum H, Parvez S, Rehman H, Dev Banerjee B, Siemen D, Raisuddin S. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Hum Exp Toxicol. 2007; 26(6): 509-518.
Miyazono Y, Gao F, Horie T. Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scand J Gastroenterol. 2004; 39(11): 1119-1127.
Jahovic N, Sener G, Cevik H, Ersoy Y, Arbak S, Yeğen BC. Amelioration of methotrexate-induced enteritis by melatonin in rats. Cell Biochem Funct. 2004; 22(3): 169-178.
Aitken RJ, Baker MA. Oxidative stress, sperm survival and fertility control. Mol Cell Endocrinol. 2006; 250(1-2): 66-69.
Aitken RJ. A free radical theory of male infertility. Reprod Fertil Dev. 1994; 6(1): 19-23.
Aitken RJ. Free radicals, lipid peroxidation and sperm function. Reprod Fertil Dev. 1995; 7(4): 659-668.
Pasqualotto FF, Sharma RK, Kobayashi H, Nelson DR, Thomas AJ Jr, Agarwal A. Oxidative stress in normospermic men undergoing infertility evaluation. J Androl. 2001; 22(2): 316-322.
Zorn B, Vidmar G, Meden-Vrtovec H. Seminal reactive oxygen species as predictors of fertilization, embryo quality and pregnancy rates after conventional in vitro fertilization and intracytoplasmic sperm injection. Int J Androl. 2003; 26(5): 279-285.
Ateşşahin A, Ceribaşi AO, Yilmaz S. Lycopene, a carotenoids, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin Pharmacol Toxicol. 2007; 100(6): 372-376.
Dinkova-Kostova AT. Protection against cancer by plant phenylpropenoids: induction of mammalian anticarcinogenic enzymes. Mini Rev Med Chem. 2002; 2(6): 595-610.
Uchiyama T, Delude RL, Fink MP. Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion. Intensive Care Med. 2003; 29(11): 2050-2058.
Song M, Kellum JA, Kaldas H, Fink MP. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J Pharmacol Exp Ther. 2004; 308(1): 307-316.
Tawadrous ZS, Delude RL, Fink MP. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock. 2002; 17(6): 473-477.
Tsung A, Kaizu T, Nakao A, Shao L, Bucher B, Fink MP. Ethyl pyruvate ameliorates liver ischemiareperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation. 2005; 79(2): 196-204.
Ajami AM, Sims CA, Fink MP. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion. United States Patent. 2004; 10: 116-707.